Inquirer Opinion on MSN2h
Game-changer for pharmaceuticals
Researchers from the University of the Philippines Manila recently developed a cost-effective painkiller made from an herbal ...
Tariffs will trigger some job losses, and impact future investment, but Ireland’s strategic value remains solid - ‘Pharma isn ...
Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as ...
How innovation, advanced manufacturing, and expertise drive success in the evolving CDMO and generics landscape.
Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.
Over 50 Years of Leadership in API Development and Manufacturing Esteve Química Wins Champion Award in the Small Molecule API ...
In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life sciences co-leader, details the Biosecure Act, including the ways pharma ...
The number of workers in manufacturing has declined, but not because America stopped making things. It's because we got ...
The World Business Council for Sustainable Development (WBCSD), in collaboration with leading pharmaceutical companies and ...
We think CR Pharma has a weaker financial position compared with the top three medical distributors. Similar to other pharmaceutical distributors, accounts receivable make up a large portion of its ...
Digging deeper into the BIO survey results, 94% of companies polled said they expect tariffs on the EU to drive up ...
Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...